The present invention provides a compound of the formula (I) wherein R is —H, or —C
1
-C
4
alkyl; R
1
is —H, —OH, —O(C
1
-C
4
alkyl), —SO
2
(C
1
-C
4
alkyl), or halo; X is —O—, —CH
2
—, or —C(O)—; X
1
is —O— or —NR
2
—; R
2
is —H or —CH
3
; Y is —S—, —CH
2
CH
2
—, or —HC═CH—; m is 0, 1, 2, or 3; and n is 0 or 1; or a pharmaceutically acceptable salt thereof; pharmaceutical compositions thereof; and methods for inhibiting a disease associated with an aberrant physiological response to endogenous estrogen.
本发明提供了式(I)化合物,其中R为—H或—C1-C4烷基;R1为—H、—OH、—O(C1-C4烷基)、—SO2(C1-C4烷基)或卤素;X为—O—、—
CH2—或—C(O)—;X1为—O—或—NR2—;R2为—H或—
CH3;Y为—S—、— —或—HC═CH—;m为0、1、2或3;n为0或1;或其药学上可接受的盐;以及用于抑制与内源性
雌激素异常生理反应相关的疾病的制药组合物和方法。